Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency

Abstract

Aim of this paper is to remind the risk of ototoxicity when using chloroquine and hydroxychloroquine, in particular as prophylactic agents against SARS-CoV-2, during the pandemic. Healthy subjects taking chloroquine and hydroxychloroquine as prophylactic agents against SARS-CoV-2, during the pandemic, should be screened periodically, at least by Otoacoustic Emissions (OAEs) in order to detect early manifestations of possible cochlear ototoxic damages.

Keywords

• Ototoxicity
• Prevention
• SARS-CoV-2 (Covid-19)
• Chloroquine
• Hydroxychloroquine